Skip to main content
رجوع
ASTH logo

Astrana Health, Inc.

جودة البيانات: 100%
ASTH
NASDAQ Healthcare Medical - Care Facilities
KWD 24.48
▲ KWD 0.46 (1.92%)
القيمة السوقية: 1.23B
نطاق اليوم
KWD 23.58 KWD 24.72
نطاق 52 أسبوعًا
KWD 18.08 KWD 34.80
حجم التداول
257,715
متوسط 50 يوم / 200 يوم
KWD 23.32 / KWD 25.81
الإغلاق السابق
KWD 24.02

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 54.6 0.2
P/B 1.6 3.0
ROE % 3.0 3.6
Net Margin % 0.7 3.8
Rev Growth 5Y % 42.4 10.0
D/E 1.4 0.2

السعر المستهدف للمحللين

Hold
KWD 32.75 +33.8%
Low: KWD 26.00 High: KWD 40.00
مكرر الربحية المستقبلي
19.81
ربحية السهم المستقبلية
KWD 1.24
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
3.99B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 3.40
KWD 3.24 – KWD 3.58
5.41B 1
FY2029 KWD 2.81
KWD 2.68 – KWD 2.96
5.02B 1
FY2028 KWD 2.21
KWD 2.11 – KWD 2.33
4.64B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-02 KWD 0.11 KWD 0.54 +408.0%
2025-11-06 KWD 0.47 KWD 0.01 -97.9%
2025-08-07 KWD 0.36 KWD 0.19 -47.2%
2025-05-08 KWD 0.23 KWD 0.14 -39.1%
2025-02-27 KWD 0.22 -KWD 0.15 -168.2%
2024-11-07 KWD 0.32 KWD 0.33 +3.1%
2024-08-07 KWD 0.39 KWD 0.40 +2.6%
2024-05-07 KWD 0.30 KWD 0.31 +3.3%

Dividend History

Yield

0.01%

Payout Ratio

0.35%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 42.39% annually over 5 years — strong growth
Earnings declined -47.89% over the past year
ROE of 3.01% is below average
Generating 104.49M in free cash flow
P/E of 54.60 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 14.00%

النمو

Revenue Growth (5Y)
42.39%
Revenue (1Y)56.39%
Earnings (1Y)-47.89%
FCF Growth (3Y)62.24%

الجودة

Return on Equity
3.01%
ROIC3.17%
Net Margin0.71%
Op. Margin2.47%

الأمان

Debt / Equity
1.38
Current Ratio1.40
Interest Coverage1.57

التقييم

P/E Ratio
54.60
Forward P/E19.81
P/B Ratio1.58
EV/EBITDA23.90
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 56.39% Revenue Growth (3Y) 51.48%
Earnings Growth (1Y) -47.89% Earnings Growth (3Y) -39.14%
Revenue Growth (5Y) 42.39% Earnings Growth (5Y) -24.42%
Profitability
Revenue (TTM) 3.18B Net Income (TTM) 22.49M
ROE 3.01% ROA 1.01%
Gross Margin 9.30% Operating Margin 2.47%
Net Margin 0.71% Free Cash Flow (TTM) 104.49M
ROIC 3.17% FCF Growth (3Y) 62.24%
Safety
Debt / Equity 1.38 Current Ratio 1.40
Interest Coverage 1.57
Dividends
Dividend Yield 0.01% Payout Ratio 0.35%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 54.60 Forward P/E 19.81
P/B Ratio 1.58 P/S Ratio 0.39
PEG Ratio -1.09 Forward PEG N/A
EV/EBITDA 23.90 Fwd EV/EBITDA 5.52
Forward P/S 0.31 Fwd Earnings Yield 5.05%
FCF Yield 8.51%
Market Cap 1.23B Enterprise Value 1.88B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.18B 2.03B 1.39B 1.14B 773.92M
Net Income 22.49M 43.15M 60.72M 45.17M 68.92M
EPS (Diluted) 0.46 0.90 1.29 0.99 1.52
Gross Profit 295.78M 271.39M 214.96M 199.48M 177.77M
Operating Income 78.53M 89.35M 84.61M 104.27M 98.18M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.22B 1.35B 933.36M 966.21M 867.36M
Total Liabilities 1.66B 840.73M 522.59M 407.67M 356.72M
Shareholders' Equity 779.29M 712.72M 614.22M 542.56M 448.17M
Total Debt 1.08B 471.84M 321.01M 229.36M 200.98M
Cash & Equivalents 429.47M 288.46M 293.81M 288.03M 233.10M
Current Assets 863.31M 638.50M 461.51M 428.13M 404.46M
Current Liabilities 615.27M 365.61M 218.67M 148.61M 114.72M

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
#309 of 1049
55

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026
دخل Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026